Seneca sells Manchester pharmaceutical facility to occupier Seda

The sale follows the building's repositioning as a specialist life sciences facility. The post Seneca sells Manchester pharmaceutical facility to occupier Seda appeared first on Property Week.

Alloga signs lease at Panattoni’s M1 logistics hub

The specialist pharmaceutical logistics provider has signed a lease for 230,000 sq ft at the East Midlands development. The post Alloga signs lease at Panattoni’s M1 logistics hub appeared first on Property Week.

Mortenson tops out Oregon pharmaceutical manufacturing facility

A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout of the commercial-scale plant. 

Lilly to build $6B weight-loss drug factory in Alabama

This is the third of four planned U.S. manufacturing sites the pharmaceutical giant has unveiled this year, set to bring 450 factory jobs to the Huntsville area.

Built Environs sets the pace in Australia’s life sciences sector

A new pharmaceutical product filling line system delivered by Built Environs. (Images: Craig Moodie)Australia’s capacity to produce vaccines and medicines at home depends on the buildings where science takes place. Such facilities are … The post Built Environs sets the pace in Australia’s life sciences sector appeared first on Inside Construction.

MK TEKNOLOGY1 PVT LTD

MK TEKNOLOGY1 PVT. LTD. is a specialized technology and solutions provider focused on cleanroom monitoring, contamination control, and environmental validation systems for regulated and high-precision industries. The company supports organizations where strict control of airborne and liquid contamination is critical to product quality, patient safety, and regulatory compliance.